BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 26427391)

  • 1. Therapeutic Approaches to Histone Reprogramming in Retinal Degeneration.
    Berner AK; Kleinman ME
    Adv Exp Med Biol; 2016; 854():39-44. PubMed ID: 26427391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetylation: a lysine modification with neuroprotective effects in ischemic retinal degeneration.
    Alsarraf O; Fan J; Dahrouj M; Chou CJ; Menick DR; Crosson CE
    Exp Eye Res; 2014 Oct; 127():124-31. PubMed ID: 25064603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone Deacetylase: Therapeutic Targets in Retinal Degeneration.
    Daly C; Yin J; Kennedy BN
    Adv Exp Med Biol; 2016; 854():455-61. PubMed ID: 26427446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic hallmarks of age-related macular degeneration are recapitulated in a photosensitive mouse model.
    Luu J; Kallestad L; Hoang T; Lewandowski D; Dong Z; Blackshaw S; Palczewski K
    Hum Mol Genet; 2020 Aug; 29(15):2611-2624. PubMed ID: 32691052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excessive HDAC activation is critical for neurodegeneration in the rd1 mouse.
    Sancho-Pelluz J; Alavi MV; Sahaboglu A; Kustermann S; Farinelli P; Azadi S; van Veen T; Romero FJ; Paquet-Durand F; Ekström P
    Cell Death Dis; 2010; 1(2):e24. PubMed ID: 21364632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone deacetylase inhibitors in the treatment for multiple myeloma.
    Hideshima T; Anderson KC
    Int J Hematol; 2013 Mar; 97(3):324-32. PubMed ID: 23475757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic modulation and understanding of HDAC inhibitors in cancer therapy.
    Ramaiah MJ; Tangutur AD; Manyam RR
    Life Sci; 2021 Jul; 277():119504. PubMed ID: 33872660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of histone deacetylases.
    Huang Y; Shaw PG; Davidson NE
    Methods Mol Biol; 2011; 791():297-311. PubMed ID: 21913088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of Histone Acetyltransferases and Deacetylases in the Retinal Development and Diseases.
    Wang J; Feng S; Zhang Q; Qin H; Xu C; Fu X; Yan L; Zhao Y; Yao K
    Mol Neurobiol; 2023 Apr; 60(4):2330-2354. PubMed ID: 36637745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acetylation of retinal histones in diabetes increases inflammatory proteins: effects of minocycline and manipulation of histone acetyltransferase (HAT) and histone deacetylase (HDAC).
    Kadiyala CS; Zheng L; Du Y; Yohannes E; Kao HY; Miyagi M; Kern TS
    J Biol Chem; 2012 Jul; 287(31):25869-80. PubMed ID: 22648458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of class II histone deacetylases in the spinal cord attenuates inflammatory hyperalgesia.
    Bai G; Wei D; Zou S; Ren K; Dubner R
    Mol Pain; 2010 Sep; 6():51. PubMed ID: 20822541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of a Fatty Acids Dietary Supplement in a Polyethylene Glycol-Induced Mouse Model of Retinal Degeneration.
    Cammalleri M; Dal Monte M; Locri F; Lardner E; Kvanta A; Rusciano D; André H; Bagnoli P
    Nutrients; 2017 Sep; 9(10):. PubMed ID: 28961167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of histone deacetylase protects the retina from ischemic injury.
    Crosson CE; Mani SK; Husain S; Alsarraf O; Menick DR
    Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3639-45. PubMed ID: 20164449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ischemic preconditioning, retinal neuroprotection and histone deacetylase activities.
    Fan J; Alsarraf O; Chou CJ; Yates PW; Goodwin NC; Rice DS; Crosson CE
    Exp Eye Res; 2016 May; 146():269-275. PubMed ID: 27060376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone deacetylases and their inhibitors: new implications for asthma and chronic respiratory conditions.
    Royce SG; Karagiannis TC
    Curr Opin Allergy Clin Immunol; 2014 Feb; 14(1):44-8. PubMed ID: 24322009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small molecule inhibitors of zinc-dependent histone deacetylases.
    Wagner FF; Weїwer M; Lewis MC; Holson EB
    Neurotherapeutics; 2013 Oct; 10(4):589-604. PubMed ID: 24101253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium propionate and sodium butyrate effects on histone deacetylase (HDAC) activity, histone acetylation, and inflammatory gene expression in bovine mammary epithelial cells.
    Silva LG; Ferguson BS; Avila AS; Faciola AP
    J Anim Sci; 2018 Dec; 96(12):5244-5252. PubMed ID: 30252114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The emerging roles of HDACs and their therapeutic implications in cancer.
    Hai R; Yang D; Zheng F; Wang W; Han X; Bode AM; Luo X
    Eur J Pharmacol; 2022 Sep; 931():175216. PubMed ID: 35988787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of histone deacetylases (HDACs) in human cancer.
    Ropero S; Esteller M
    Mol Oncol; 2007 Jun; 1(1):19-25. PubMed ID: 19383284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulation of histone deacetylases in ocular diseases.
    Jun JH; Kim JS; Palomera LF; Jo DG
    Arch Pharm Res; 2024 Jan; 47(1):20-39. PubMed ID: 38151648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.